Preston-Maher Georgia L, Torii Ryo, Burriesci Gaetano
Cardiovascular Engineering Laboratory, UCL Mechanical Engineering, Torrington Place, London, WC1E 7JE UK.
Cardiovasc Eng Technol. 2015 Jun;6(2):174-84. doi: 10.1007/s13239-014-0203-9. Epub 2014 Nov 25.
Mitral regurgitation is one of the most common forms of heart valve disorder, which may result in heart failure. Due to the rapid ageing of the population, surgical repair and replacement treatments, which have represented an effective treatment in the past, are now unsuitable for about half of symptomatic patients, who are judged high-risk. Encouraged by the positive experience with transcatheter aortic valves and percutaneous reconstructive mitral treatments, a number of research groups are currently engaged in the development of minimally invasive approaches for the functional replacement of the mitral valve. The first experiences have clearly demonstrated that the approach is feasible and promising, though significant progress is still required in the prostheses design and implantation procedures before the treatment can establish as a safe and effective solution. This review analyses the devices currently at a most advanced stage of development, describing their main features and the technical solutions that they adopt in order to respond to the functional requirements of the most challenging of the heart valves.
二尖瓣反流是心脏瓣膜疾病最常见的形式之一,可能导致心力衰竭。由于人口快速老龄化,过去曾是有效治疗方法的外科修复和置换治疗,现在约有一半有症状的高危患者不适用。受到经导管主动脉瓣和经皮二尖瓣重建治疗的积极经验鼓舞,一些研究小组目前正致力于开发二尖瓣功能置换的微创方法。首批经验已清楚表明该方法可行且前景广阔,不过在治疗成为安全有效的解决方案之前,人工瓣膜设计和植入程序仍需取得重大进展。本综述分析了目前处于最先进开发阶段的器械,描述了它们的主要特征以及为满足最具挑战性的心脏瓣膜功能需求而采用的技术方案。